$8.41
+0.15 (+1.82%)
As of May 9, 1:48 AM ET ·
Analyst Consensus
Strong Buy
9
Analysts
Moderate
Coverage
Buy 8 89%
Hold 1 11%
Sell 0 0%
Price Target
Analyst Price Target +245.1% upside
Low Target $25.25
Average Target $29.02
High Target $47.24
Current Price $8.41
Current
$8.41
Target
$29.02
$25.25 $29.02 avg $47.24
Scenario Analysis
Bear Case
$25.25
200.2%
Low target
Base Case
$29.02
+245.1%
Avg target
Bull Case
$47.24
+461.7%
High target
Risk/Reward
2.3x
Favorable
Price in Context
52-Week High
$9.35
-10.1% from high
52-Week Low
$6.50
+29.4% from low
Target vs 52W High
$29.02
+210.4% vs high
Next Earnings Report
May 13, 2026 · Before Market Open
2d
until earnings
EPS Est: $0.12
Earnings in 2 days. Analyst targets may shift significantly after the report.
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Strong Buy 40 75% $257.58 +27.8%
AMGN
Amgen Inc
Hold 44 48% $190.87 -42.5%
GILD
Gilead Sciences Inc
Strong Buy 39 79% $362.68 +176.2%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 39 79% $438.34 +2.0%
REGN
Regeneron Pharmaceuticals
Strong Buy 38 79% $76.80 -89.3%
ALNY
Alnylam Pharmaceuticals Inc
Strong Buy 36 75% $102.31 -65.3%
RVMD
Revolution Medicines Inc
Strong Buy 27 96% $114.11 -19.5%
INSM
Insmed Inc
Strong Buy 28 96% $143.40 +41.5%